Antiphospholipid antibodies in pulmonary embolism treated with direct oral anticoagulants: Prevalence data from unselected consecutive patients-Reference-Cited by-同舟云学术

Antiphospholipid antibodies in pulmonary embolism treated with direct oral anticoagulants: Prevalence data from unselected consecutive patients

Published:2023-01 Issue:1 Volume:7 Page:100050
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Research and Practice in Thrombosis and Haemostasis

Author:

Justinussen Tummas^ORCID,Gram Jorgen Brodersen,Bor Mustafa Vakur

Publisher

Elsevier BV

Subject

Hematology

Reference24 articles.

1. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS);Konstantinides;Euro Heart J,2020

2. National Institute for Health and Care Excellence. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. NG158. March 26, 2020. Available from: https://www.nice.org.uk/guidance/ng158.

3. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS);Miyakis;J Thromb Haemost,2006

4. Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis;Zuily;J Thromb Haemost,2020

5. Addendum to British Society for Haematology Guidelines on Investigation and Management of Antiphospholipid syndrome, 2012 (Br J Haematol. 2012;157:47-58): use of direct acting oral anticoagulants;Arachchillage;Br J Haematol,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiphospholipid-Syndrom;Springer Reference Medizin;2024